Suppr超能文献

脂溢性皮炎和特应性皮炎患者中的马拉色菌属

[Malassezia species in patients with seborrheic dermatitis and atopic dermatitis].

作者信息

Tajima Mami

机构信息

Department of Dermatology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.

出版信息

Nihon Ishinkin Gakkai Zasshi. 2005;46(3):163-7. doi: 10.3314/jjmm.46.163.

Abstract

Malassezia species, organisms normally colonizing the skin surface, are thought to play a role as either the cause or an exacerbating factor in a number of skin conditions, including pityriasis versicolor, Malassezia folliculitis, seborrheic dermatitis (SD) and atopic dermatitis (AD). Using a non-cultural PCR method, we analyzed Malassezia spp. extracted from the skin surface of SD and AD patients. The species most commonly detected in both patient groups were M. globosa and M. restricta, and the number of Malassezia spp. In these patients was higher than in healthy subjects. After a topical application of 2% ketoconazole cream, changes in the population of Malassezia spp. in 20 intractable cases of AD were recorded. The addition of the 2% ketoconazole cream to the standard topical treatments was found to have reduced the Malassezia spp. population by 90%, and showed a clinical efficacy rate of 70%. Furthermore, a combination of azole agents and tacrolimus produced a synergistic anti-fungal effect against Malassezia spp. in vitro. A clinical trial using this drug combination conducted on the face and neck of patients with intractable AD showed a 66.6% efficacy rate in both the reduction of the flora and in clinical improvement. From these results it was evident that Malassezia is one of the factors exacerbating AD, and that removal of the organism results in an improvement in the clinical condition of the patient.

摘要

马拉色菌属是通常定植于皮肤表面的微生物,被认为在多种皮肤疾病中起病因或加重因素的作用,这些疾病包括花斑糠疹、马拉色菌毛囊炎、脂溢性皮炎(SD)和特应性皮炎(AD)。我们使用非培养PCR方法分析了从SD和AD患者皮肤表面提取的马拉色菌属。在两个患者组中最常检测到的菌种是球形马拉色菌和限制马拉色菌,并且这些患者体内马拉色菌属的数量高于健康受试者。在局部应用2%酮康唑乳膏后,记录了20例难治性AD患者中马拉色菌属数量的变化。发现在标准局部治疗中添加2%酮康唑乳膏可使马拉色菌属数量减少90%,临床有效率为70%。此外,唑类药物和他克莫司的组合在体外对马拉色菌属产生了协同抗真菌作用。在难治性AD患者的面部和颈部使用这种药物组合进行的一项临床试验显示,在减少菌群和临床改善方面的有效率均为66.6%。从这些结果可以明显看出,马拉色菌是加重AD的因素之一,清除该微生物可改善患者的临床状况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验